4.5 Article

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Temozolomide for treatment-resistant recurrent meningioma

MC Chamberlain et al.

NEUROLOGY (2004)

Review Clinical Neurology

Meningioma pathology, genetics, and biology

K Lamszus

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)

Article Clinical Neurology

Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas

U Andersson et al.

ACTA NEUROPATHOLOGICA (2004)